CN101601656A - 依达拉奉脂质体注射剂及其新应用 - Google Patents
依达拉奉脂质体注射剂及其新应用 Download PDFInfo
- Publication number
- CN101601656A CN101601656A CNA2009100167047A CN200910016704A CN101601656A CN 101601656 A CN101601656 A CN 101601656A CN A2009100167047 A CNA2009100167047 A CN A2009100167047A CN 200910016704 A CN200910016704 A CN 200910016704A CN 101601656 A CN101601656 A CN 101601656A
- Authority
- CN
- China
- Prior art keywords
- edaravone
- phospholipid
- lipidosome injection
- cholesterol
- polyoxyethylene sorbitan
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Medicinal Preparation (AREA)
Abstract
Description
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2009100167047A CN101601656B (zh) | 2009-07-03 | 2009-07-03 | 依达拉奉脂质体注射剂及其新应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2009100167047A CN101601656B (zh) | 2009-07-03 | 2009-07-03 | 依达拉奉脂质体注射剂及其新应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101601656A true CN101601656A (zh) | 2009-12-16 |
CN101601656B CN101601656B (zh) | 2010-08-18 |
Family
ID=41467654
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2009100167047A Expired - Fee Related CN101601656B (zh) | 2009-07-03 | 2009-07-03 | 依达拉奉脂质体注射剂及其新应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101601656B (zh) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102429879A (zh) * | 2011-11-29 | 2012-05-02 | 海南灵康制药有限公司 | 一种盐酸氨溴索脂质体注射剂 |
CN103040868A (zh) * | 2012-12-17 | 2013-04-17 | 海南百思特医药科技有限公司 | 肌氨肽苷脂质体注射剂 |
CN105816423A (zh) * | 2016-03-16 | 2016-08-03 | 福建康是美生物科技有限公司 | 依达拉奉剂型 |
CN112043632A (zh) * | 2020-08-19 | 2020-12-08 | 上海中翊日化有限公司 | 一种葡萄籽提取物双包裹体的应用 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN100358520C (zh) * | 2003-09-11 | 2008-01-02 | 彭建华 | 具有良好稳定性的注射用依达拉奉粉针剂及其制备方法 |
CN1660119A (zh) * | 2004-12-22 | 2005-08-31 | 王剑 | 维生素d3前体脂质体组合物及其制备方法 |
CN101439043A (zh) * | 2007-11-20 | 2009-05-27 | 中国人民解放军第二军医大学 | 一种替尼泊苷注射剂及其制备方法 |
-
2009
- 2009-07-03 CN CN2009100167047A patent/CN101601656B/zh not_active Expired - Fee Related
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102429879A (zh) * | 2011-11-29 | 2012-05-02 | 海南灵康制药有限公司 | 一种盐酸氨溴索脂质体注射剂 |
CN102429879B (zh) * | 2011-11-29 | 2013-05-29 | 海南灵康制药有限公司 | 一种盐酸氨溴索脂质体注射剂 |
CN103040868A (zh) * | 2012-12-17 | 2013-04-17 | 海南百思特医药科技有限公司 | 肌氨肽苷脂质体注射剂 |
CN105816423A (zh) * | 2016-03-16 | 2016-08-03 | 福建康是美生物科技有限公司 | 依达拉奉剂型 |
CN109125261A (zh) * | 2016-03-16 | 2019-01-04 | 苏州澳宗生物科技有限公司 | 依达拉奉剂型 |
CN111840218A (zh) * | 2016-03-16 | 2020-10-30 | 苏州澳宗生物科技有限公司 | 依达拉奉剂型 |
US11020375B2 (en) | 2016-03-16 | 2021-06-01 | Suzhou Auzone Biological Technology Co., Ltd. | Edaravone dosage form |
CN112043632A (zh) * | 2020-08-19 | 2020-12-08 | 上海中翊日化有限公司 | 一种葡萄籽提取物双包裹体的应用 |
Also Published As
Publication number | Publication date |
---|---|
CN101601656B (zh) | 2010-08-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101601654B (zh) | 盐酸法舒地尔脂质体注射剂及其新应用 | |
CN101601656B (zh) | 依达拉奉脂质体注射剂及其新应用 | |
JP5919597B2 (ja) | デオキシコール酸およびその塩類の製剤 | |
KR20150129665A (ko) | 심각한 통증 치료를 위한 조성물 및 방법 | |
CA2917815C (en) | Organophosphates for treating afflictions of the skin | |
CN100370994C (zh) | 克林霉素甲硝唑软膏及其制备方法 | |
CN103505409A (zh) | 一种丁苯酞注射液及其制备方法 | |
Storm et al. | A comparative study on the antitumor effect, cardiotoxicity and nephrotoxicity of doxorubicin given as a bolus, continuous infusion or entrapped in liposomes in the Lou/M Wsl rat | |
CN107519136A (zh) | 一种氯化琥珀胆碱冻干制剂及其制备方法 | |
US20230165796A1 (en) | Treating microvascular dysfunction | |
CN101601655B (zh) | 马来酸桂哌齐特脂质体注射剂及其新应用 | |
CN101632681A (zh) | 甘油果糖脂质体药物组合物注射剂及制备方法 | |
JP2016147890A (ja) | デオキシコール酸およびその塩類の製剤 | |
CN101912362B (zh) | 一种替尼泊苷静脉注射用脂肪乳预乳化浓缩液及其制备方法 | |
CN101849915A (zh) | 异长春花碱隐形脂质体冻干粉针剂及其制备方法 | |
JP7015237B2 (ja) | 腫瘍の成長を抑制する方法 | |
KR20130091093A (ko) | 데옥시콜린산 나트륨이 없는 포스파티딜콜린 함유 주사제 조성물 및 이의 제조방법 | |
AU2014283264C1 (en) | Stereospecific lipids for locoregional therapy with long-term circulating stimuli-sensitive nanocarrier systems | |
CN102973503B (zh) | 一种去甲斑蝥素衍生物脂质微球注射液及其制备方法 | |
CN100377712C (zh) | 葫芦素脂质体组方及其制剂 | |
CN101147728A (zh) | 6-甲氧基双脱氧鸟苷长循环脂质体制剂及制备方法 | |
CN101822640B (zh) | 一种磺苄西林钠脂质体注射剂 | |
CN102091326B (zh) | 治疗因肛门皮下的静脉丛发生扩大或曲张所引发的痔类疾病的经皮给药制剂及制备方法 | |
CN101904817B (zh) | 一种头孢磺啶钠脂质体注射剂 | |
CN106176608A (zh) | 培美曲塞二钠注射剂及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: HAINAN RUIJI PHARMACEUTICAL CO., LTD. Free format text: FORMER OWNER: WANG MING Effective date: 20101019 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 570125 ROOM 2601, XINDA BUSINESS BUILDING, NO.48, GUOMAO AVENUE, HAIKOU CITY, HAINAN PROVINCE TO: 570000 ROOM 415, YUKE PLAZA, SCIENCE AVENUE, NATIONAL HIGH-TECH. AREA, HAIKOU CITY, HAINAN PROVINCE |
|
TR01 | Transfer of patent right |
Effective date of registration: 20101019 Address after: 570000 room 415, Yu Cheng Building, science and technology Avenue, national hi tech Zone, Haikou, Hainan Patentee after: Hainan Ruiji Pharmaceutical Co., Ltd. Address before: The new business building No. 48 570125 Hainan city of Haikou province China World Trade Center Road, room 2601 Patentee before: Wang Ming |
|
DD01 | Delivery of document by public notice |
Addressee: Zhu Yunqin Document name: Notification of Passing Examination on Formalities |
|
EE01 | Entry into force of recordation of patent licensing contract |
Assignee: Hainan Lingkang Pharmaceutical Co., Ltd. Assignor: Hainan Ruiji Pharmaceutical Co., Ltd. Contract record no.: 2011370000117 Denomination of invention: Edaravone liposome injection and new application thereof Granted publication date: 20100818 License type: Exclusive License Open date: 20091216 Record date: 20110421 |
|
ASS | Succession or assignment of patent right |
Owner name: HAINAN MEILAN SHIKE PHARMACEUTICAL CO., LTD. Free format text: FORMER OWNER: HAINAN RUIJI PHARMACEUTICAL CO., LTD. Effective date: 20130724 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 570000 HAIKOU, HAINAN PROVINCE TO: 570216 HAIKOU, HAINAN PROVINCE |
|
TR01 | Transfer of patent right |
Effective date of registration: 20130724 Address after: 6, No. 570216, Haikou Free Trade Zone, 168 Nanhai Avenue, Hainan, Haikou Patentee after: Hainan Meilan Shike Pharmaceutical Co., Ltd. Address before: 570000 room 415, Yu Cheng Building, science and technology Avenue, national hi tech Zone, Haikou, Hainan Patentee before: Hainan Ruiji Pharmaceutical Co., Ltd. |
|
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20100818 Termination date: 20160703 |